Abad M - Search Results

1

Multiple novel alternative splicing forms of FBXW7α have a translational modulatory function and show specific alteration in human cancer.

Liu Y, Ren S, Castellanos-Martin A, Perez-Losada J, Kwon YW, Huang Y, Wang Z, Abad M, Cruz-Hernandez JJ, Rodriguez CA, Sun Y, Mao JH. Liu Y, et al. Among authors: abad m. PLoS One. 2012;7(11):e49453. doi: 10.1371/journal.pone.0049453. Epub 2012 Nov 14. PLoS One. 2012. PMID: 23166673 Free PMC article.

2

Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer.

de Alava E, Ocaña A, Abad M, Montero JC, Esparís-Ogando A, Rodríguez CA, Otero AP, Hernández T, Cruz JJ, Pandiella A. de Alava E, et al. Among authors: abad m. J Clin Oncol. 2007 Jul 1;25(19):2656-63. doi: 10.1200/JCO.2006.08.6850. J Clin Oncol. 2007. PMID: 17602072

3

New models towards assessing anti-cancer therapeutics.

Romero-Camarero I, Barajas-Diego M, Castellanos-Martín A, García-Martín Á, Varela G, Abad M, Ludeña MD, Pérez-Losada J, Sánchez-García I. Romero-Camarero I, et al. Among authors: abad m. Histol Histopathol. 2012 Feb;27(2):157-70. doi: 10.14670/HH-27.157. Histol Histopathol. 2012. PMID: 22207550 Free article. Review.

4

C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes.

Lu J, Wen M, Huang Y, He X, Wang Y, Wu Q, Li Z, Castellanos-Martin A, Abad M, Cruz-Hernandez JJ, Rodriguez CA, Pérez-Losada J, Mao JH, Wei G. Lu J, et al. Among authors: abad m. Epigenetics. 2013 Jun;8(6):571-83. doi: 10.4161/epi.24626. Epub 2013 Apr 26. Epigenetics. 2013. PMID: 23770814 Free PMC article.

5

iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers.

Mao XY, Perez-Losada J, Abad M, Rodríguez-González M, Rodríguez CA, Mao JH, Chang H. Mao XY, et al. Among authors: abad m. World J Clin Oncol. 2022 Jul 24;13(7):616-629. doi: 10.5306/wjco.v13.i7.616. World J Clin Oncol. 2022. PMID: 36157157 Free PMC article.

6

PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2- breast cancer.

Terán E, Lozano R, Rodríguez CA, Abad M, Figuero L, Muñoz JA, Cigarral B, Rodrígues A, Sancho M, Gómez MA, Morchón D, Montero JC, Sayagués JM, Ludeña MD, Fonseca E. Terán E, et al. Among authors: abad m. Cancer Med. 2024 Sep;13(17):e70101. doi: 10.1002/cam4.70101. Cancer Med. 2024. PMID: 39235099 Free PMC article.

7

Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer.

Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Santaballa A, Rodríguez CA, Crespo C, Abad M, Domínguez S, Florián J, Llorca C, Méndez M, Godes M, Cubedo R, Murias A, Batista N, García MJ, Caballero R, de Alava E. Martín M, et al. Among authors: abad m. Breast Cancer Res Treat. 2010 Aug;123(1):149-57. doi: 10.1007/s10549-009-0663-z. Breast Cancer Res Treat. 2010. PMID: 20037779 Clinical Trial.

8

Imatinib is not a potential alternative treatment for uterine leiomyosarcoma.

Serrano C, Mackintosh C, Herrero D, Martins AS, de Alava E, Hernández T, Pérez-Fontán J, Abad M, Pérez A, Serrano E, Bullón A, Orfao A. Serrano C, et al. Among authors: abad m. Clin Cancer Res. 2005 Jul 1;11(13):4977-9; author reply 4979-80. doi: 10.1158/1078-0432.CCR-04-2461. Clin Cancer Res. 2005. PMID: 16000598 Free article. No abstract available.

9

Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target.

Montero JC, Ocaña A, Abad M, Ortiz-Ruiz MJ, Pandiella A, Esparís-Ogando A. Montero JC, et al. Among authors: abad m. PLoS One. 2009;4(5):e5565. doi: 10.1371/journal.pone.0005565. Epub 2009 May 15. PLoS One. 2009. PMID: 19440538 Free PMC article.

10

Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer.

Montero JC, Esparís-Ogando A, Re-Louhau MF, Seoane S, Abad M, Calero R, Ocaña A, Pandiella A. Montero JC, et al. Among authors: abad m. Oncogene. 2014 Jan 9;33(2):148-56. doi: 10.1038/onc.2012.572. Epub 2012 Dec 17. Oncogene. 2014. PMID: 23246963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

490 results

Search Page

Filters